TSS
DGX icon

Two Sigma Securities’s Quest Diagnostics DGX Stock Holding History

Two Sigma Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,300
Closed -$512K – 2022
2024
Q3 		$512K Sell
3,300
-7,300
-69% -$1.09M 0.01% 1299
2024
Q2 		$1.45M Sell
10,600
-11,700
-52% -$1.6M 0.02% 876
2024
Q1 		$2.97M Buy
22,300
+5,500
+33% +$714K 0.03% 585
2023
Q4 		$2.32M Sell
16,800
-2,200
-12% -$289K 0.02% 636
2023
Q3 		$2.32M Sell
19,000
-3,800
-17% -$506K 0.02% 626
2023
Q2 		$3.2M Buy
22,800
+13,000
+133% +$1.79M 0.05% 425
2023
Q1 		$1.39M Buy
9,800
+3,200
+48% +$458K 0.03% 677
2022
Q4 		$1.03M Sell
6,600
-100
-1% -$14.4K 0.03% 674
2022
Q3 		$822K Buy
6,700
+2,500
+60% +$329K 0.02% 757
2022
Q2 		$559K Buy
4,200
+200
+5% +$27.3K 0.02% 833
2022
Q1 		$547K Buy
+4,000
New +$558K 0.02% 947
2020
Q4 		– Sell
-8,400
Closed -$962K – 1723
2020
Q3 		$962K Buy
+8,400
New +$992K 0.02% 363
2020
Q1 		– Sell
-26,100
Closed -$2.79M – 1550
2019
Q4 		$2.79M Buy
26,100
+16,500
+172% +$1.72M 0.02% 603
2019
Q3 		$1.03M Buy
9,600
+3,600
+60% +$370K 0.01% 862
2019
Q2 		$611K Buy
6,000
+3,100
+107% +$298K 0.01% 981
2019
Q1 		$261K Sell
2,900
-2,800
-49% -$243K ﹤0.01% 1288
2018
Q4 		$475K Sell
5,700
-16,600
-74% -$1.56M 0.01% 1016
2018
Q3 		$2.41M Sell
22,300
-1,700
-7% -$186K 0.02% 623
2018
Q2 		$2.64M Hold
24,000
– – 0.01% 758
2018
Q1 		$2.41M Buy
24,000
+21,200
+757% +$2.17M 0.01% 771
2017
Q4 		$276K Buy
+2,800
New +$265K 0.01% 1054

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Two Sigma Securities's DGX Position: Q1 2026 in Review

Two Sigma Securities reduced its Quest Diagnostics (DGX) stake by 38% in Q1 2026, selling an estimated $177K and leaving 1,490 shares worth $292K. The position accounts for 0.03% of the portfolio, ranked #792.

Two Sigma Securities first reported a position in DGX in Q1 2017 and has held it in 17 quarters since. The position peaked at $1.21M in Q3 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Two Sigma Securities held 1,490 shares of Quest Diagnostics worth $292K as of Q1 2026.
  • Two Sigma Securities sold 912 Quest Diagnostics shares in Q1 2026, an estimated $177K.
  • Quest Diagnostics made up 0.03% of Two Sigma Securities's portfolio in Q1 2026, its #792 holding.
  • Two Sigma Securities first reported a position in Quest Diagnostics in Q1 2017 and has held it in 17 quarters since.
  • Two Sigma Securities's Quest Diagnostics position peaked at $1.21M in Q3 2025.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.